GSK3 beta (GSK3B) pSer9 (incl. pos. control) Mouse Monoclonal Antibody [Clone ID: 3A8]

CAT#: AM00067PU-N

GSK3 beta (GSK3B) pSer9 (incl. pos. control) mouse monoclonal antibody, clone 3A8, Purified

Conjugation: Unconjugated Biotin



Need it in bulk or conjugated?
Get a free quote

CNY 5,973.00


货期*
5周

规格
    • 100 ug

Product images

Specifications

Product Data
Clone Name 3A8
Applications ELISA, WB
Recommend Dilution Western Blot: 0.5 µg/ml for HRPO/ECL detection.
Recommended blocking buffer: Casein/Tween 20 based blocking and blot incubation buffer.
ELISA: 0,05 µg/ml.
Reactivity Canine, Human, Mouse
Host Mouse
Clonality Monoclonal
Immunogen Synthetic phosphopeptide conjugated to KLH.
Specificity This antibody specifically recognizes GSK3beta phosphorylated at Ser 9 at 46 kDa.
Formulation 1 ml 2 x PBS / 0.09 % Na-azide / PEG and Sucrose
State: Purified
State: Lyophilized purified IgG
Reconstitution Method Restore with 1 ml H2O (15 min, RT).
Purification Size exclusion chromatography
Conjugation Unconjugated
Storage Condition Store lyophilized (preferably in a desiccator) at -20°C and reconstituted (aliquote and freeze in liquid nitrogen) at -80°C.
Avoid repeated freezing and thawing.
Thaw aliquots at 37°C. Thawed aliquots may be stored at 4°C up to 3 months.
Gene Name glycogen synthase kinase 3 beta
Background Glycogen Synthase Kinase 3 beta (GSK3beta) is a serine/threonine kinase that is acting independently of most signal transduction pathways. The activity of GSK3beta can be modulated by phosphorylation of Ser9 and Tyr215 in the activation loop. GSK3beta plays a crucial role in phosphorylation of beta-catenin and thus is an important kinase involved in the regulation of beta-catenin/wnt-signaling.
Synonyms GSK-3 beta, Glycogen synthase kinase-3 beta, GSK3B
Reference Data
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...